{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:48:45Z","timestamp":1792802925925,"version":"4.5.0"},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1248\/bpb.b19-00699","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:08:51Z","timestamp":1577812131000},"page":"138-144","source":"Crossref","is-referenced-by-count":21,"title":["The Synthetic Curcumin Derivative CNB-001 Attenuates Thrombin-Stimulated Microglial Inflammation by Inhibiting the ERK and p38 MAPK Pathways"],"prefix":"10.1248","volume":"43","author":[{"given":"Tatsuhiro","family":"Akaishi","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Abe","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Liu Y, Dargusch R, Maher P, Schubert D. A broadly neuroprotective derivative of curcumin. J. Neurochem.<\/i>, 105<\/b>, 1336\u20131345 (2008).","DOI":"10.1111\/j.1471-4159.2008.05236.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Maher P, Akaishi T, Schubert D, Abe K. A pyrazole derivative of curcumin enhances memory. Neurobiol. Aging<\/i>, 31<\/b>, 706\u2013709 (2010).","DOI":"10.1016\/j.neurobiolaging.2008.05.020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology<\/i>, 129<\/b>, 154\u2013169 (2010).","DOI":"10.1111\/j.1365-2567.2009.03225.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Guillot-Sestier MV, Doty KR, Town T. Innate immunity fights Alzheimer\u2019s disease. Trends Neurosci.<\/i>, 38<\/b>, 674\u2013681 (2015).","DOI":"10.1016\/j.tins.2015.08.008"},{"key":"5","unstructured":"5) Mhatre SD, Tsai CA, Rubin AJ, James ML, Andreasson KI. Microglial malfunction: the third rail in the development of Alzheimer\u2019s disease. Trends Neurosci.<\/i>, 38<\/b>, 621\u2013636 (2015)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tremblay M-\u00c8, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J. Neurosci.<\/i>, 31<\/b>, 16064\u201316069 (2011).","DOI":"10.1523\/JNEUROSCI.4158-11.2011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Krenzlin H, Lorenz V, Danckwardt S, Kempski O, Alessandri B. The importance of thrombin in cerebral injury and disease. Int. J. Mol. Sci.<\/i>, 17<\/b>, 84 (2016).","DOI":"10.3390\/ijms17010084"},{"key":"8","unstructured":"8) Luo W, Wang Y, Reiser G. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res. Rev.<\/i>, 56<\/b>, 331\u2013345 (2007)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Su P, Zhang J, Wang D, Zhao F, Cao Z, Aschner M, Luo W. The role of autophagy in modulation of neuroinflammation in microglia. Neuroscience<\/i>, 319<\/b>, 155\u2013167 (2016).","DOI":"10.1016\/j.neuroscience.2016.01.035"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Akaishi T, Abe K. CNB-001, a synthetic pyrazole derivative of curcumin, suppresses lipopolysaccharide-induced nitric oxide production through the inhibition of NF-\u03baB and p38 MAPK pathways in microglia. Eur. J. Pharmacol.<\/i>, 819<\/b>, 190\u2013197 (2018).","DOI":"10.1016\/j.ejphar.2017.12.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer\u2019s disease. Neurosci. Lett.<\/i>, 146<\/b>, 152\u2013154 (1992).","DOI":"10.1016\/0304-3940(92)90065-F"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chen B, Cheng Q, Yang K, Lyden PD. Thrombin mediates severe neurovascular injury during ischemia. Stroke<\/i>, 41<\/b>, 2348\u20132352 (2010).","DOI":"10.1161\/STROKEAHA.110.584920"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron<\/i>, 6<\/b>, 575\u2013581 (1991).","DOI":"10.1016\/0896-6273(91)90060-D"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Festoff BW, Sajja RK, van Dreden P, Cucullo L. HMGB1 and thrombin mediate the blood\u2013brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease. J. Neuroinflammation<\/i>, 13<\/b>, 194 (2016).","DOI":"10.1186\/s12974-016-0670-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ohnishi M, Monda A, Takemoto R, Matsuoka Y, Kitamura C, Ohashi K, Shibuya H, Inoue A. Sesamin suppresses activation of microglia and p44\/42 MAPK pathway, which confers neuroprotection in rat intracerebral hemorrhage. Neuroscience<\/i>, 232<\/b>, 45\u201352 (2013).","DOI":"10.1016\/j.neuroscience.2012.11.057"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Katsuki H, Okawara M, Shibata H, Kume T, Akaike A. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J. Neurochem.<\/i>, 97<\/b>, 1232\u20131242 (2006).","DOI":"10.1111\/j.1471-4159.2006.03752.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) M\u00f6ller T, Hanisch UK, Ransom BR. Thrombin-induced activation of cultured rodent microglia. J. Neurochem.<\/i>, 75<\/b>, 1539\u20131547 (2000).","DOI":"10.1046\/j.1471-4159.2000.0751539.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via<\/i> protein kinase C, mitogen-activated protein kinase, and NF-\u03baB. J. Biol. Chem.<\/i>, 275<\/b>, 29955\u201329959 (2000).","DOI":"10.1074\/jbc.M001220200"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Suo Z, Wu M, Ameenuddin S, Anderson HE, Zoloty JE, Citron BA, Andrade-Gordon P, Festoff BW. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem.<\/i>, 80<\/b>, 655\u2013666 (2002).","DOI":"10.1046\/j.0022-3042.2001.00745.x"},{"key":"20","unstructured":"20) Flaumenhaft R, De Ceunynck K. Targeting PAR1: now what? Trends Pharmacol. Sci.<\/i>, 38<\/b>, 701\u2013716 (2017)."},{"key":"21","unstructured":"21) French SL, Hamilton JR. Protease-activated receptor 4: from structure to function and back again. Br. J. Pharmacol.<\/i>, 173<\/b>, 2952\u20132965 (2016)."},{"key":"22","unstructured":"22) Hollenberg MD, Mihara K, Polley D, Suen JY, Han A, Fairlie DP, Ramachandran R. Biased signaling and proteinase-activated receptors (PARs): targeting inflammatory disease. Br. J. Pharmacol.<\/i>, 171<\/b>, 1180\u20131194 (2014)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy\u2014From molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta Proteins Proteomics<\/i>, 1754<\/b>, 253\u2013262 (2005).","DOI":"10.1016\/j.bbapap.2005.08.017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res.<\/i>, 872<\/b>, 141\u2013148 (2000).","DOI":"10.1016\/S0006-8993(00)02517-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Carre\u00f1o-M\u00fcller E, Herrera AJ, de Pablos RM, Tom\u00e1s-Camardiel M, Venero JL, Cano J, Machado A. Thrombin induces in vivo<\/i> degeneration of nigral dopaminergic neurones along with the activation of microglia. J. Neurochem.<\/i>, 84<\/b>, 1201\u20131214 (2003).","DOI":"10.1046\/j.1471-4159.2003.01634.x"},{"key":"26","unstructured":"26) Choi SH, Lee DY, Kim SU, Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo<\/i>: role of microglial NADPH oxidase. J. Neurosci.<\/i>, 25<\/b>, 4082\u20134090 (2005)."},{"key":"27","unstructured":"27) Lee DY, Park KW, Jin BK. Thrombin induces neurodegeneration and microglial activation in the cortex in vivo<\/i> and in vitro<\/i>: proteolytic and non-proteolytic actions. Biochem. Biophys. Res. Commun.<\/i>, 346<\/b>, 727\u2013738 (2006)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Li C, Wang J, Fang Y, Liu Y, Chen T, Sun H, Zhou XF, Liao H. Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats. Brain Behav. Immun.<\/i>, 56<\/b>, 230\u2013245 (2016).","DOI":"10.1016\/j.bbi.2016.03.019"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chen CW, Chen QB, Ouyang Q, Sun JH, Liu FT, Song DW, Yuan HB. Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation. J. Neuroinflammation<\/i>, 9<\/b>, 142 (2012).","DOI":"10.1186\/1742-2094-9-142"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Suo Z, Wu M, Citron BA, Gao C, Festoff BW. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J. Biol. Chem.<\/i>, 278<\/b>, 31177\u201331183 (2003).","DOI":"10.1074\/jbc.M302137200"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Henrich-Noack P, Riek-Burchardt M, Baldauf K, Reiser G, Reymann KG. Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Res.<\/i>, 1070<\/b>, 232\u2013241 (2006).","DOI":"10.1016\/j.brainres.2005.10.100"},{"key":"32","unstructured":"32) Wen W, Young SE, Duvernay MT, Schulte ML, Nance KD, Melancon BJ, Engers J, Locuson CW 2nd, Wood MR, Daniels JS, Wu W, Lindsley CW, Hamm HE, Stauffer SR. Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: discovery and SAR of ML354. Bioorg. Med. Chem. Lett.<\/i>, 24<\/b>, 4708\u20134713 (2014)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Steinberg SF. The cardiovascular actions of protease-activated receptors. Mol. Pharmacol.<\/i>, 67<\/b>, 2\u201311 (2005).","DOI":"10.1124\/mol.104.003103"},{"key":"34","unstructured":"34) Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev.<\/i>, 26<\/b>, 1\u201343 (2005)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wilson TJ, Nannuru KC, Singh RK. Cathepsin G recruits osteoclast precursors via<\/i> proteolytic activation of protease-activated receptor-1. Cancer Res.<\/i>, 69<\/b>, 3188\u20133195 (2009).","DOI":"10.1158\/0008-5472.CAN-08-1956"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ahn HS, Foster C, Boykow G, Stamford A, Manna M, Graziano M. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H<\/i>-pyrrolo[3,2-f<\/i>]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem. Pharmacol.<\/i>, 60<\/b>, 1425\u20131434 (2000).","DOI":"10.1016\/S0006-2952(00)00460-3"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00699\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:14:37Z","timestamp":1578269677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00699\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00699","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}